We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approval for Genentech’s Subcutaneous Rituximab

News   Mar 31, 2017 | Original Story from Genentech

 
FDA Approval for Genentech’s Subcutaneous Rituximab
 
 
 

RELATED ARTICLES

Zika Vaccine Shows Promise For Treating Deadly Brain Cancer

News

A Zika vaccine candidate has shown promise as a treatment for the deadliest type of brain cancer.

READ MORE

Experimental Nasal Influenza Vaccine Tested in Kids, Teens

News

NIH-supported Phase 1 trial of potential broadly protective vaccine.

READ MORE

Antibodies.com Appoints CEO

News

CEO appointment marks a step change in growth strategy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE